National Health Investors (NHI) Receivables (2009 - 2026)

National Health Investors' Receivables history runs 18 years deep, the most recent figure standing at $3.3 million for Q1 2026.

• Quarterly Receivables rose 65.63% year-over-year to $3.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.3 million (up 65.63% YoY) and the FY2025 annual result came in at $3.1 million, down 68.71% from the prior year.
• Receivables was $3.3 million for Q1 2026 at National Health Investors, up from $3.1 million in the prior quarter.
• Across five years, Receivables topped out at $10.0 million in Q4 2024 and bottomed at $2.0 million in Q1 2025.
• A 5-year average of $6.8 million and a median of $8.0 million in 2023 frame the typical range for Receivables.
• Annual changes were most pronounced in 2023 — Receivables soared 167.88% — and 2025, when it tumbled 79.42%.
• National Health Investors' Receivables stood at $3.6 million in 2022, then surged by 167.88% to $9.7 million in 2023, then climbed by 3.35% to $10.0 million in 2024, then slumped by 68.71% to $3.1 million in 2025, then rose by 5.39% to $3.3 million in 2026.
• Business Quant data shows NHI's Receivables at $3.3 million in Q1 2026, $3.1 million in Q4 2025, and $3.6 million in Q3 2025.